What is ePrescribe?

Published in Member Communities on February 08, 2022

Ken HodelTechnology and software companies in the HME industry continue to make advancements to help automate and speed up otherwise manual processes that could take hours or days. But why hasn’t electronic prescribing of HME taken off? Ken Hodel, vice president of development for DMEScripts, recently discussed ePrescribe with HME News. Read the full HME News Article here.

What is ePrescribe?

A. Electronic prescribing of medications and lab tests has been a part of the healthcare ecosystem for almost 20 years. It has been proven to improve quality of care, reduce errors, increase efficiency and lower administrative costs. However, these results have yet to be broadly replicated in the DME industry. In the past, e-prescribe for DME was largely focused on electronic transmission of data and documentation with little concern for the accuracy or qualification of the order. The result was simply a well formatted electronic fax that still needed to go back and forth multiple times before the DME provider could get paid. However, in the past few years, a new crop of true DME e-prescribe platforms has emerged.

What is a true DME ePrescribe platform?

All four of the DME e-prescribe platforms (DMEscripts, eOrders Plus, GoScripts, Parachute Health) are centered around producing complete and accurate DME orders. Unlike the e-faxed orders that come out of an electronic health record (EHR) or referral management platform, a high percentage of DME e-prescribe orders come with a billable and refillable prescription in addition to the accompanying documentation to prove medical necessity for the item being ordered. The orders produced by these platforms reduce, and many times remove, the rework that is inherent in the current fax and phone-based DME ordering process.  

Read the full article from HME News


TAGS

  1. business solution
  2. technology

From Our Experts

What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers thumbnail What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers Read what the proposed Numotion/Hanger merger could mean for CRT and O&P providers from VGM's SVP of Membership, Tyler Mahncke. What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers thumbnail What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers Read what the proposed Numotion/Hanger merger could mean for CRT and O&P providers from VGM's SVP of Membership, Tyler Mahncke. Turning Unmet OSA Need Into Measurable Referral Growth thumbnail Turning Unmet OSA Need Into Measurable Referral Growth Discover strategies for HME providers to convert undiagnosed OSA into referral growth by enhancing PCP relationships and improving patient care outcomes. Turning Unmet OSA Need Into Measurable Referral Growth thumbnail Turning Unmet OSA Need Into Measurable Referral Growth Discover strategies for HME providers to convert undiagnosed OSA into referral growth by enhancing PCP relationships and improving patient care outcomes. Before You Add a New Product Line, Ask These Seven Questions thumbnail Before You Add a New Product Line, Ask These Seven Questions Explore the key reimbursement, accreditation, compliance, and operational considerations DMEPOS providers should evaluate before expanding services. A Pattern We're Seeing Across Healthcare thumbnail A Pattern We're Seeing Across Healthcare Insights on how healthcare providers can build trust, clarity, & confidence for patients, referral sources, & employees while navigating industry complexity. Medicare DMEPOS Compliance Updates: New F2F, WOPD, & Prior Authorization Requirements thumbnail Medicare DMEPOS Compliance Updates: New F2F, WOPD, & Prior Authorization Requirements Medicare is expanding DMEPOS compliance requirements, with new Face-to-Face (F2F), Written Order Prior to Delivery (WOPD), and Prior Authorization rules taking effect in 2026 and 2027. What AI and Industry Leaders Predict for HME's Future thumbnail What AI and Industry Leaders Predict for HME's Future Discover why HME growth remains strong despite reimbursement uncertainty, increased audits, staffing challenges, and operational pressures.